GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (BSP:C1NC34) » Definitions » EV-to-FCF

Centene (BSP:C1NC34) EV-to-FCF : 5.60 (As of Apr. 25, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Centene EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Centene's Enterprise Value is R$205,621 Mil. Centene's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was R$36,719 Mil. Therefore, Centene's EV-to-FCF for today is 5.60.

The historical rank and industry rank for Centene's EV-to-FCF or its related term are showing as below:

BSP:C1NC34' s EV-to-FCF Range Over the Past 10 Years
Min: -100.57   Med: 9.62   Max: 339.69
Current: 5.51

During the past 13 years, the highest EV-to-FCF of Centene was 339.69. The lowest was -100.57. And the median was 9.62.

BSP:C1NC34's EV-to-FCF is ranked better than
85.71% of 14 companies
in the Healthcare Plans industry
Industry Median: 15.29 vs BSP:C1NC34: 5.51

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), Centene's stock price is R$390.78. Centene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was R$24.634. Therefore, Centene's PE Ratio for today is 15.86.


Centene EV-to-FCF Historical Data

The historical data trend for Centene's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene EV-to-FCF Chart

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.86 8.52 17.06 9.95 5.38

Centene Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.95 4.61 5.09 6.53 5.38

Competitive Comparison of Centene's EV-to-FCF

For the Healthcare Plans subindustry, Centene's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centene's EV-to-FCF Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Centene's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Centene's EV-to-FCF falls into.



Centene EV-to-FCF Calculation

Centene's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=205620.521/36718.904
=5.60

Centene's current Enterprise Value is R$205,621 Mil.
Centene's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$36,719 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Centene  (BSP:C1NC34) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Centene's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=390.78/24.634
=15.86

Centene's share price for today is R$390.78.
Centene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$24.634.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Centene EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Centene's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Centene (BSP:C1NC34) Business Description

Traded in Other Exchanges
Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Centene (BSP:C1NC34) Headlines

No Headlines